Cargando…
Morin promotes prostate cancer cells chemosensitivity to paclitaxel through miR-155/GATA3 axis
Paclitaxel is a first-line microtubule-stabilizing drug in treating prostate cancer. However, most patients develop resistance and experience relapse. Morin (3,5,7,20,40-pentahydroxyflavone) is an anti-tumor flavonoid in a numerous types of cancer cells including breast, ovarian and lung cancers. We...
Autores principales: | Li, Bin, Jin, Xunbo, Meng, Huilin, Hu, Bo, Zhang, Tao, Yu, Jiang, Chen, Shaoan, Guo, Xudong, Wang, Weiguo, Jiang, Wei, Wang, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564610/ https://www.ncbi.nlm.nih.gov/pubmed/28599307 http://dx.doi.org/10.18632/oncotarget.18133 |
Ejemplares similares
-
MiR-145 inhibits cell migration and increases paclitaxel chemosensitivity in prostate cancer cells
por: Tohidast, Maryam, et al.
Publicado: (2023) -
Paul Morin /
por: Morin, Paul, 1889-1957
Publicado: (1958) -
The effect of propofol on chemosensitivity of paclitaxel in cervical cancer cells
por: Jin, Yanshan, et al.
Publicado: (2023) -
NT21MP negatively regulates paclitaxel-resistant cells by targeting miR-155-3p and miR-155-5p via the CXCR4 pathway in breast cancer
por: Wang, Yueyue, et al.
Publicado: (2018) -
GATA6-AS1 via Sponging miR-543 to Regulate PTEN/AKT Signaling Axis Suppresses Cell Proliferation and Migration in Gastric Cancer
por: Jin, Yi, et al.
Publicado: (2023)